Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pamidronate dosing schedule trial for chronic non-specific low back pain
ACTRN12615001193561Phase 4Completed
- Sponsor
- Bay of Plenty District Health Board
- Start
- Mar 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of pamidronate in Low back pain (LBP) (2 arms), sponsored by Bay of Plenty District Health Board. Primary endpoint: Proportion of patients with improvement in pain scores. Started Mar 2016; status: completed.
02
Drugs
pamidronate
03
Conditions
Low back pain (LBP)
Beyond the preview
Go deeper on ACTRN12615001193561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615001193561.